DBN1 and cancer: Collectively, our findings suggest that the oncogenic roles of MXD3 are concomitantly associated with deregulation of DBN1, RAB24, SLC34A1, PRELID1, LMAN2, F12, GRK6, RGS14, PRR7, and PFN3 in various cancer types.